Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 316 AL 330

Electronic organiser and Alzheimer's disease: fact or fiction?

Imbeault H, Bier N, Pigot H, Gagnon L, Marcotte N, Fulop T, Giroux S.

Neuropsychol Rehabil. 2014;24(1):71-100. doi: 10.1080/09602011.2013.858641. Epub 2013 Dec 23.

Tau-aggregation inhibitor therapy for Alzheimer's disease

Wischik CM, Harrington CR, Storey JM.

Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19.

A caregiver's wish list for a National Alzheimer's Agenda

Vann AS.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):111-3. doi: 10.1177/1533317513511292. Epub 2013 Dec 26.

Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele

Qiu WW, Lai A, Mon T, Mwamburi M, Taylor W, Rosenzweig J, Kowall N, Stern R, Zhu H, Steffens DC.

Am J Geriatr Psychiatry. 2014 Feb;22(2):177-85. doi: 10.1016/j.jagp.2012.08.017. Epub 2013 Apr 3.

[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]

Cruz Jentoft AJ, Hernández B.

Neurologia. 2014 Jan-Feb;29(1):1-10. doi: 10.1016/j.nrl.2013.01.008. Epub 2013 Apr 10.

A randomized cross-over controlled study on cognitive rehabilitation of instrumental activities of daily living in Alzheimer disease

Thivierge S, Jean L, Simard M.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1188-99. doi: 10.1016/j.jagp.2013.03.008. Epub 2013 Jul 17.

The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review

Farina N, Rusted J, Tabet N.

Int Psychogeriatr. 2014 Jan;26(1):9-18. doi: 10.1017/S1041610213001385. Epub 2013 Aug 20.

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response

Wilkinson D, Wirth Y, Goebel C.

Dement Geriatr Cogn Disord. 2014;37(1-2):71-85. doi: 10.1159/000353801. Epub 2013 Oct 3.

Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial

Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE.

Int Psychogeriatr. 2014 Feb;26(2):239-46. doi: 10.1017/S1041610213001762. Epub 2013 Oct 29.

N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499

Dessolin J.

Expert Opin Ther Pat. 2014 Feb;24(2):239-42. doi: 10.1517/13543776.2014.859246. Epub 2013 Nov 13.

The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective

Whitehouse PJ.

Biochem Pharmacol. 2014 Apr 15;88(4):677-81. doi: 10.1016/j.bcp.2013.11.017. Epub 2013 Dec 1.

Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial

Lin CH, Chen PK, Chang YC, Chuo LJ, Chen YS, Tsai GE, Lane HY.

Biol Psychiatry. 2014 May 1;75(9):678-85. doi: 10.1016/j.biopsych.2013.08.010. Epub 2013 Sep 25.

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

Blennow K, Hampel H, Zetterberg H.

Neuropsychopharmacology. 2014 Jan;39(1):189-201. doi: 10.1038/npp.2013.154. Epub 2013 Jun 25.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020

Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B.

Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Epub 2013 Nov 22.

Latino Alzheimer's disease caregivers and depression: using the stress coping model to examine the effects of spirituality and religion

Sun F, Hodge DR.

J Appl Gerontol. 2014 Apr;33(3):291-315. doi: 10.1177/0733464812444462. Epub 2012 May 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias